$SHBI

Shore Bancshares Inc (NASDAQ:SHBI) Given Consensus Rating of "Moderate Buy" by Analysts

Shore Bancshares Inc (NASDAQ:SHBI) has received a consensus "Moderate Buy" rating from analysts, with an average 12-month price target of $20.1667. The company recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend. Insider buying and institutional investor activity also indicate confidence in the stock.

Original reporting
MarketBeat · MarketBeat
Published Apr 18, 2026, 10:37 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Apr 18, 2026, 11:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Shore Bancshares Inc (NASDAQ:SHBI) Given Consensus Rating of "Moderate Buy" by Analysts — source image
Decision brief

The 30-second read

$SHBIBullishMed
01

Why it matters

The positive earnings and analyst ratings have led to increased insider buying and institutional interest, which may drive the stock price higher in the near term.

02

Market read

The news is highly relevant for investors interested in regional banking stocks, with potential implications for similar institutions.

03

What to watch

Potential regulatory changes or unforeseen economic shocks could impact bank profitability and stock performance.

Relevance 6/10Timing: short to medium term (next 3-6 months)

Background

Shore Bancshares Inc recently reported strong quarterly earnings, exceeding analyst expectations, and announced a quarterly dividend, signaling financial health and shareholder confidence.

Company-level read

Ticker impact

$SHBIBullishHigh confidence
Context

The news directly pertains to Shore Bancshares Inc, providing relevant financial outlooks and analyst ratings.

Expected impact

Potential 5-10% increase over the next 3-6 months if current trends persist.

Evidence & confidence

Strong earnings beat, analyst ratings, and insider buying indicate positive momentum; however, market conditions could influence actual performance.

Market effects

The banking sector may see increased investor confidence, potentially benefiting regional banks with similar profiles.

Positive sentiment could boost regional financial markets, especially in areas where SHBI operates.

Limited; the news primarily affects regional banking and financial markets.

Counterpoint

If interest rates decline or economic conditions worsen, SHBI's stock could underperform despite current positive indicators.

Key entities

  • Shore Bancshares Inc

    A regional bank providing banking services and financial products.

Related articles

$SHBIMed

Shore Bancshares, Inc. Reports 2026 Third Quarter Results

SHORE BANCSHARES INC (SHBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 18 E. Dover Street Easton, Maryland 21601 Phone (410) 763-7800 PRESS RELEASE Shore Bancshares, Inc. Reports 2026 Third Quarter Results Easton, Maryland (October 22, 2026) – Shore Bancshares, Inc. (NASDAQ – SHBI) (the “Company” or “Shore Bancshares”), the holding comp

$SHBIMed

Shore Bancshares, Inc. Reports 2026 Third Quarter Results

Shore Bancshares (SHBI) reported Q3 2026 net income of $16.8M, down from Q2 2026 but up from Q3 2025. PTPP increased to $27.5M, ROAA was 1.08%, and NIM rose to 3.78%. Nonperforming assets increased to 1.27% of total assets. The company repurchased shares and declared a dividend. Total assets grew to $6.45B, driven by cash and securities increases.

$SHBIMed

Shore Bancshares, Inc. Reports 2026 Second Quarter Results

SHORE BANCSHARES INC (SHBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 shbi-20260630xexx991.htm EX-99.1 Document Exhibit 99.1 18 E. Dover Street Easton, Maryland 21601 Phone (410) 763-7800 PRESS RELEASE Shore Bancshares, Inc. Reports 2026 Second Quarter Results Easton, Maryland (July 23, 2026) – Shore Bancshares, Inc. (NASDAQ – SHBI) (the

$RIOMed

Rio Tinto invests $1.9 billion in Queensland bauxite project

Rio Tinto plans to invest $1.9 billion in the Kangwinan bauxite project in Queensland, Australia, adding 20 million tonnes of annual production capacity by 2032. The project will replace output from the Andoom mine and compensate for the end of Gove mine production. Construction is set to begin in 2027, with an expected internal rate of return of 22%.

$ATRLow

AptarGroup names Virginie Maes president of pharma unit

AptarGroup Inc. (NYSE: ATR) appointed Virginie Maes as President of Aptar Pharma, effective January 1, 2027. Maes joins from Amcor, where she led global pharma and medical packaging. She has prior experience at McKinsey, Terra Firma, and Morgan Stanley. ATR is a provider of drug delivery and consumer product dispensing technologies.